Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Part of paid clinical trials in Montgomery, Alabama.

Sponsor
Amgen
Study ID
NCT00005959
Phase
PHASE2
Status
Unknown

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • filgrastim — BIOLOGICAL
  • rituximab — BIOLOGICAL
  • cyclophosphamide — DRUG
  • doxorubicin hydrochloride — DRUG
  • prednisone — DRUG
  • vincristine sulfate — DRUG

Study Details

RATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one chemotherapy drug with rituximab may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of rituximab plus combination chemotherapy in treating patients who have intermediate-grade or high-grade non-Hodgkin's lymphoma.

Key Dates

Start date
Dec 31, 1999
Status verified
Jun 2002

Study Design

Primary purpose
TREATMENT

Locations (27)

FacilityCityStateZIPSite coordinators
Montgomery Cancer CenterMontgomeryAlabama36106-
University of Arkansas for Medical SciencesLittle RockArkansas72205-
Providence Saint Joseph Medical Center - BurbankBurbankCalifornia91505-
Cancer and Blood Institute of the DesertRancho MirageCalifornia92270-
Southeast Florida Hematology-Oncology GroupFort LauderdaleFlorida33308-
Oncology-Hematology Group of South FloridaMiamiFlorida33176-
Mount Sinai Comprehensive Cancer CenterMiami BeachFlorida33140-
Hematology-Oncology Associates, PAPensacolaFlorida32501-
Hutchinson Clinic, P.A.HutchinsonKansas67502-
Hematology/Oncology Care Inc.Crestview HillsKentucky41017-
Maine Center for Cancer Medicine and Blood DisordersScarboroughMaine04074-
Associates in Oncology and HematologyRockvilleMaryland20850-
North Shore Cancer CenterPeabodyMassachusetts01960-
Henry Ford HospitalDetroitMichigan48202-
Lakeland Medical Center - St. JosephSaint JosephMichigan49085-
Bond ClinicRollaMissouri65401-
Midwest Hematology Oncology Consultants, Ltd.St LouisMissouri63136-
Hematology Oncology AssociatesMorristownNew Jersey07962-
New Mexico Oncology-HematologyAlbuquerqueNew Mexico87109-
HemOnCare, P.C.BrooklynNew York11235-
Our Lady of Mercy Medical CenterThe BronxNew York10466-
N.W. Carolina Oncology & Hematology, P.A.HickoryNorth Carolina28603-
Oncology/Hematology Care, Inc.CincinnatiOhio45219-
University of Tennessee, MemphisMemphisTennessee38163-
Intermountain Hematology/Oncology Associates, Inc.Salt Lake CityUtah84124-
Vermont Center for Cancer Medicine, Inc.ColchesterVermont05446-
Hematology & Oncology Associates of VirginiaRichmondVirginia23226-

Find similar trials in Montgomery, AL

By research site
Montgomery Cancer Center· Montgomery, ALUniversity of Arkansas for Medical Sciences· Little Rock, ARProvidence Saint Joseph Medical Center - Burbank· Burbank, CACancer and Blood Institute of the Desert· Rancho Mirage, CASoutheast Florida Hematology-Oncology Group· Fort Lauderdale, FLOncology-Hematology Group of South Florida· Miami, FL

Related Studies